Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Researchers evaluated the changing risk of severe COVID-19 outcomes in individuals with primary and secondary immunodeficiencies in the context of COVID-19 vaccinations.

17 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

In a recent study published in the International Journal of Infectious Diseases, researchers assessed the efficacy of coronavirus disease 2019 (COVID-19) vaccines in people living with human immunodeficiency virus (HIV).

16 Oct 2022

A rare case of Hashimoto encephalopathy after COVID vaccination

In a recent ‘Letter to the Editor’ published in the English edition of the journal Neurologandiacute, researchers reported the rare occurrence of Hashimoto encephalopathy in a recipient of the (COVID-19) vaccine Spikevax. Spikevax, research name mRNA-1273, is a COVID-19 vaccine based on the messenger ribonucleic acid (mRNA) technology.

16 Oct 2022

Transition in the management of COVID-19

A review of the current approaches to managing COVID-19, including diagnostic, therapeutic, and preventive measures.

16 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

Omicron sublineage BA.2.75.2 largely resistant to several monoclonal antibody antiviral treatments

A study at Karolinska Institutet in Sweden shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments.

14 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Rapidly fading antibody levels in recovered COVID-19 patients associated with plasma metabolites

A study led by Hong Kong Baptist University (HKBU) has revealed the association between rapidly fading antibody levels in some recovered COVID-19 patients and a high plasma concentration of a metabolite called glycylproline (gly-pro) and its producing enzyme.

14 Oct 2022

Will covid spike again this fall? 6 tips to help you stay safe

Last year, the emergence of the highly transmissible omicron variant of the covid-19 virus caught many people by surprise and led to a surge in cases that overwhelmed hospitals and drove up fatalities. Now we're learning that omicron is mutating to better evade the immune system.

14 Oct 2022

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Researchers examined single clones of SARS-CoV-2-specific memory B cells to understand their adaptability and fate.

13 Oct 2022

Researchers develop an HERV-enveloped recombinant baculoviral DNA vaccine against SARS-CoV-2

Researchers developed a human endogenous retrovirus (HERV)-enveloped recombinant baculoviral DNA vaccine to target the SARS-CoV-2 Delta variant, and tested its cross-protection efficacy using mice models.

13 Oct 2022

Antibody response to COVID-19 vaccine not associated with time of day of vaccination

A study in Japan finds antibody response to the Moderna COVID-19 mRNA vaccine does not vary depending on the time of day when the dose was received.

12 Oct 2022

Modeling the risk factors for household transmission of SARS-CoV-2

Researchers analyze the risks of contracting SARS-CoV-2 from the household and community

12 Oct 2022

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

An experimental approach to enhancing a standard cat allergy treatment made it more effective and faster acting, and the benefits persisted for a year after treatment ended, a study supported by the National Institutes of Health has found.

11 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022

Antibody response trajectories among solid organ transplant recipients in association with mycophenolate mofetil administration

Researchers explored the trajectory of antibody (Ab) titers after coronavirus disease 2019 (COVID-19) vaccination among solid organ transplant recipients (SOTs) with or without mycophenolate mofetil (MMF), or withdrawn from MMF.

11 Oct 2022

Oxford researchers report findings from Phase 1 clinical trial of intranasal COVID-19 vaccine

Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the safety and immune response of an intranasally-administered vaccine against COVID-19.

11 Oct 2022

Study provides new insights into the origin and development of B cells

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill.

11 Oct 2022

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

A recent Cell Reports study evaluated humoral responses induced after the second and third doses of the mRNA vaccine.

11 Oct 2022

Antibody News and Research

Further Reading

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

A rare case of Hashimoto encephalopathy after COVID vaccination

Transition in the management of COVID-19

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

Omicron sublineage BA.2.75.2 largely resistant to several monoclonal antibody antiviral treatments

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Rapidly fading antibody levels in recovered COVID-19 patients associated with plasma metabolites

Will covid spike again this fall? 6 tips to help you stay safe

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Researchers develop an HERV-enveloped recombinant baculoviral DNA vaccine against SARS-CoV-2

Antibody response to COVID-19 vaccine not associated with time of day of vaccination

Modeling the risk factors for household transmission of SARS-CoV-2

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Duke receives federal funding for HIV vaccine research

Antibody response trajectories among solid organ transplant recipients in association with mycophenolate mofetil administration

Oxford researchers report findings from Phase 1 clinical trial of intranasal COVID-19 vaccine

Study provides new insights into the origin and development of B cells

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

Using single B cell screening to boost antibody discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo